AI-Powered
Pathology

From discovery to diagnostics, AI powers our HALO software suite and services.

Transformative Digital Pathology Solutions​

Advance your pathology research with our AI-powered image analysis and collaborative image management platforms.

 

Accelerate diagnostics and advance clinical research with a comprehensive suite of tools for image evaluation, collaboration, and clinical trial management.

HALO AP Dx is a FDA-cleared case-centric pathology platform that enables primary diagnosis, remote working, and other routine workflows in anatomic pathology.

CE-IVD marked AI tool that detects and grades prostate adenocarcinoma in core needle biopsy specimens

Quantifies PD-L1 expression in NSCLC IHC

Quantifies HER2, ER, PR, and Ki67 IHC expression levels in primary invasive breast cancer

Detects air bubbles, tissue folds, and other common artifacts present in H&E- and IHC-stained whole slide images

Quantifies tumor content and generates tumor density heatmap to guide ROI selection for macrodissection in NSCLC

Quantifies tumor content and generates tumor density heatmap to guide ROI selection for macrodissection in colorectal cancer

Our AI-enabled services offering includes Pharma Services and AWS hosted HALO Cloud Services.

Explore Our Integrated Platforms

Learn how all of our HALO products fit together to offer an end-to-end digital pathology workflow from basic science research to clinical diagnostics!

 

Indica Labs’ AI-Powered Pathology is Utilized in Labs Around the World

Years of industry leading artificial intelligence
0 +
Global deployments
0 +
Deployments in all top 20 Pharma companies
0 /20
Peer-reviewed customer publications
0 +
Employees in 12 countries
0 +

What Our Customers & Partners Have to Say

Moving our HALO deployments to the cloud with Cloud Services has decreased monthly costs substantially and has allowed us to easily collaborate with other research institutions across the country.

Dr. C. Dirk Keene, Professor

Pathology Leader, University of Washington Department of Laboratory Medicine ​

This is a truly groundbreaking partnership designed to accelerate the advent of next-generation AI-enabled solutions in cancer diagnostics. Leica Biosystems is proud to partner with Indica Labs to develop and deliver a world-class computational pathology solution to customers and their patients.

Gustavo Perez-Fernandez

President of Leica Biosystems​

Indica Labs’ HALO is by far the most accurate, versatile, and user friendly digital image analysis platform that I have used. … HALO is a must have for any pathologist or scientist involved in quantifying immunohistochemical stains. In addition the HALO AI module is extremely easy to use. Within 20 minutes I was able to set up AI detection of tumor vs. normal tissue, as well as tumor epithelium vs stroma. HALO provides everything one needs for quantification of IHC for clinical and pre-clinical studies (of course with supervision of a pathologist). Best of all: it is fun, like a video game for Pathologists!

Philip Martin

Senior Pathologist, AstraZeneca

The deployment of HALO AP at IPATIMUP will allow us to dive into the important step of precise quantification of biomarkers. The use of Breast IHC AI and Lung PD-L1 AI from Indica Labs, under the umbrella of our demanding quality control system, promises efficient and high-quality tools for the best patient care.

Dr. Prof. Eloy​

Head of the Pathology Laboratory of IPATIMUP and Professor of Medicine at The University of Porto​

HALO is a user-friendly, and invaluable for quantification of multi-omics imaging data (MIBI, CODEX/Akoya multiplex stains, RNA-ISH/RNAscope). Cell segmentation, quantitation of tissue microarray data, aligning serial images, exporting quantitative data and .fcs files, it is incredible. The support team is incredibly responsive and collaborative.

Dr. Michael Kattah, MD, PhD

Assistant Professor, University of California, San Francisco

The implementation of HALO AP for digital tissue medicine at the University of Bern represents a major step towards streamlining diagnostic workflows and preparing for a future with AI-enabled pathology. We anticipate that deploying digital pathology in a secure AWS environment tailored to our institute’s needs will positively impact turnaround time, diagnostic quality and will ultimately contribute to improving patient care.

Prof. Dr. Aurel Perren​

Institute of Tissue Medicine and Pathology at the University of Bern​

The partnership with Indica Labs, a market leader in digital pathology, with interoperable workflow integration, will enable pathologists and labs to deliver faster, more accurate, and more reproducible answers using Lunit’s AI solution.

Dr. Brandon Suh, MD

CEO, Lunit

Our team of pathologists did an extensive comparative analysis of digital pathology platforms including HALO AP, and all pathologists in our group graded HALO AP as the platform of choice for case annotation, collaboration, and usability.

Doug Olson, CIO

Chief Information Officer, Versant Diagnostics ​

Using HALO AP has made an enormous difference to the way I work. It is much easier to review complex cases and consult with colleagues. Frankly, if you took away my digital pathology system I’d probably retire, the reason being I can do things faster and more accurately than I can with glass.

Dr. David Clark, MD

Clinical Lead for Digital Pathology Implementation, Nottingham University Hospitals NHS Trust

The selection of the HALO AP platform from Indica Labs represents a huge advance in our digital pathology capabilities. HALO AP’s user-friendly interface greatly enhances our ability to interpret complex morphological features. Digital pathology is not only streamlining diagnostic workflows but also laying the essential groundwork for AI-driven analysis. This integration marks a significant step toward more accurate, efficient, and data-driven pathology practices. By embracing these technologies, we are positioning ourselves at the forefront of the next generation in medical diagnostics.

Prof. Peter Regitnig​

The Diagnostics & Research Institute for Pathology at the Medical University of Graz​

Latest News

Catch up on the latest blogs, press releases, publications, and other news at Indica Labs.

No more posts to show

Read What Our Customers Are Publishing

Webinars & Events

Check out our upcoming and most popular webinars and events!

AACR 2025

27 – 30 April 2025 | Stop by our booth #2524 to see live demonstrations of HALO®, HALO AI, and HALO Link or prebook a meeting at our booth.

Learn More »

Towards Open Pathology: Facilitating Development of Novel AI-based Tools for Digital Pathology through Collaboration and Integration

16 October 2022 | In this 1-hour workshop, Eric Runde, Chief Operating Officer at Indica Labs, will introduce Indica’s platforms, our collaborative approach to incorporating artificial intelligence (AI) into life science and clinical workflows, and the open pathology tools available to developers and industry partners. Dr. Peter Caie, Principal Scientist

Learn More »

Towards Open Pathology: Facilitating Development of Novel AI-based Tools for Digital Pathology through Collaboration and Integration

16 October 2022 | In this 1-hour workshop, Eric Runde, Chief Operating Officer at Indica Labs, will introduce Indica’s platforms, our collaborative approach to incorporating artificial intelligence (AI) into life science and clinical workflows, and the open pathology tools available to developers and industry partners. Dr. Peter Caie, Principal Scientist

Learn More »

Our Open Pathology Partners

Scroll to Top